AI Article Synopsis
- The study compares patients with implantable loop recorders (ILR) for unexplained fainting against a control group without the devices using German claims data.
- ILR patients had a mean age of 68 and demonstrated a 1.2-year longer lifespan compared to controls.
- A higher percentage of ILR patients, 25%, received therapeutic devices, suggesting that ILRs may improve diagnosis, treatment, and survival rates.
Article Abstract
This study compares the outcomes of patients who receive an implantable loop recorder (ILR) for unexplained syncope to a control group without the diagnostic device in German claims data. Patients with ILR were matched to a control group based on prior syncope events, age, gender and Charlson Comorbidity index (CCI). Survival, syncope hospitalizations, treatment and costs were compared. Four hundred and twelve ILR patients were matched with controls, mean age was 68, mean CCI was 2.7, 42% females. ILR patients lived on average 1.2 years longer than patients in the control group. Twenty-five percent of ILR patients received a therapeutic device compared with 5% in the control group. ILRs might help to diagnose and treat patients with positive impact on survival.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/cer-2020-0242 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!